Tower Research Capital LLC (Trc) Corcept Therapeutics Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.53 Billion
- Q2 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 18,222 shares of CORT stock, worth $1.56 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
18,222
Previous 21,498
15.24%
Holding current value
$1.56 Million
Previous $2.46 Million
45.54%
% of portfolio
0.04%
Previous 0.07%
Shares
28 transactions
Others Institutions Holding CORT
# of Institutions
467Shares Held
82.8MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.41 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$827 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$660 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$536 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$331 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $9.16B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...